Table. 4.

Unacceptable results from the four evaluation compo­nents

Sample False neg/pos Variant type Zygo­sity Nomen­cla­ture Total
NGS(G)-17-01 0/0 1 2 3
NGS(G)-17-02 2/0 1 3
NGS(G)-18-01 24/3 7 34
NGS(G)-18-02 7/2 1 10
NGS(G)-18-03 4/0 1 3 7 15
NGS(G)-18-04 0/2 1 1 4
NGS(G)-19-01 3/0 5 8
NGS(G)-19-02 3/1 2 3 9
NGS(G)-19-03 1/0 2 3
NGS(G)-19-04 0/0
NGS(G)-19-05 12/0 2 5 19
Total 56/8 1 11 32 108

Abbreviation: NGS, next-generation sequencing.

Lab Med Qual Assur 2020;42:48~53 https://doi.org/10.15263/jlmqa.2020.42.1.48
© Lab Med Qual Assur